Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Increase With Exercise for Predicting Cardiovascular Mortality in Patients With Heart Failure

American Journal of Cardiology

Volumn 101, Issue 8, 2008, Pages 1157-1162

  Koç, Mevlüt ^a   Bozkurt, Abdi ^a   Acartürk, Esmeray ^a   Şahin, Durmus Yildiray ^a   Ünal, Ilker ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REST; SYMPTOMATOLOGY;

ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REST; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SYSTOLE;

EID: 41349089680     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.070     Document Type: Article

References (29)

1. Davidson N.C., Naas A.A., Hanson J.K., Kennedy N.S., Coutie W.J., and Struthers A.D. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 77 (1996) 828-831
2. Moe G.W. B-type natriuretic peptide in heart failure. Curr Opin Cardiol 21 (2006) 208-214
3. de Groote P., Millaire A., Pigny P., Nugue O., Racadot A., and Ducloux G. Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure. J Heart Lung Transplant 16 (1997) 956-963
4. Kallistratos M.S., Dritsas A., Laoutaris I.D., and Cokkinos D.V. No incremental clinical information of NT pro BNP at peak exercise over resting levels in patients with impaired left ventricular function. Int J Cardiol 121 (2007) 221-223
5. de Groote P., Soudan B., Lamblin N., Rouaix-Emery N., Mc Fadden E., Meurice T., Mouquet F., and Bauters C. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?. Am Heart J 148 (2004) 349-355
6. Friedl W., Mair J., Thomas S., Pichler M., and Puschendorf B. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise. Clin Chim Acta 281 (1999) 121-126
7. Matsumoto A., Hirata Y., Momomura S., Suzuki E., Yokoyama I., Sata M., Ohtani Y., and Serizawa T. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 129 (1995) 139-145
8. Steele I.C., McDowell G., Moore A., Campbell N.P., Shaw C., Buchanan K.D., and Nicholls D.P. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest 27 (1997) 270-276
9. Wijbenga J.A., Balk A.H., Boomsma F., Man in 't Veld A.J., and Hall C. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice. Eur Heart J 20 (1999) 1424-1428
10. Kato M., Kinugawa T., Ogino K., Endo A., Osaki S., Igawa O., Hisatome I., and Shigemasa C. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure. J Intern Med 248 (2000) 309-315
11. McNairy M., Gardetto N., Clopton P., Garcia A., Krishnaswamy P., Kazanegra R., Ziegler M., and Maisel A.S. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J 143 (2002) 406-411
12. Kinugawa T., Kato M., Ogino K., Osaki S., Tomikura Y., Igawa O., Hisatome I., and Shigemasa C. Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. Int J Cardiol 87 (2003) 83-90
13. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 88 (1995) 551-556
14. Nicholson S., Richards M., Espiner E., Nicholls G., and Yandle T. Atrial and brain natriuretic peptide response to exercise in patients with ischaemic heart disease. Clin Exp Pharmacol Physiol 20 (1993) 535-540
15. Bentzen H., Pedersen R.S., Nyvad O., and Pedersen E.B. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. Int J Cardiol 93 (2004) 121-130
16. Kato M., Kinugawa T., Omodani H., Osaki S., Ogino K., Hisatome I., Miyakoda H., and Fujimoto Y. Augmented response in plasma atrial natriuretic peptide to dynamic exercise in patients with congestive heart failure. Jpn Circ J 60 (1996) 909-916
17. Kruger S., Graf J., Merx M.W., Stickel T., Kunz D., Hanrath P., and Janssens U. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol 95 (2004) 49-54
18. Kjaer A., Appel J., Hildebrandt P., and Petersen C.L. Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects. Eur J Heart Fail 6 (2004) 29-39
19. Gardin J.M., Adams D.B., Douglas P.S., Feigenbaum H., Forst D.H., Fraser A.G., Grayburn P.A., Katz A.S., Keller A.M., Kerber R.E., et al., American Society of Echocardiography. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 15 (2002) 275-290
20. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
21. Passino C., Poletti R., Bramanti F., Prontera C., Clerico A., and Emdin M. Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. Eur J Heart Fail 8 (2006) 46-53
22. Luchner A., Burnett Jr. J.C., Jougasaki M., Hense H.W., Heid I.M., Muders F., Riegger G.A., and Schunkert H. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 18 (2000) 1121-1128
23. Groenning B.A., Nilsson J.C., Sondergaard L., Kjaer A., Larsson H.B., and Hildebrandt P.R. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail 3 (2001) 699-708
24. Mariano-Goulart D., Eberlé M.C., Boudousq V., Hejazi-Moughari A., Piot C., Caderas de Kerleau C., Verdier R., Barge M.L., Comte F., et al. Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. Eur J Heart Fail 5 (2003) 481-488
25. Kotaska K., Popelova J., Tiserova M., Telekes P., Vrzanova M., Bronsky J., Halacova M., Kukacka J., and Prusa R. NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150 (2006) 125-130
26. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., Ohnishi M., Sawaki M., Fujii M., Horie H., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 20 (1999) 1799-1807
27. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., Ohnishi M., Sugimoto Y., and Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
28. Doust J.A., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure. BMJ 330 (2005) 625
29. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743